Details for New Drug Application (NDA): 075090
✉ Email this page to a colleague
The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Pharmacology for NDA: 075090
Mechanism of Action | DNA Polymerase Inhibitors |
Medical Subject Heading (MeSH) Categories for 075090
Suppliers and Packaging for NDA: 075090
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 075090 | ANDA | A-S Medication Solutions | 50090-5610 | 50090-5610-0 | 25 CAPSULE in 1 BOTTLE (50090-5610-0) |
ACYCLOVIR | acyclovir | CAPSULE;ORAL | 075090 | ANDA | A-S Medication Solutions | 50090-5610 | 50090-5610-1 | 50 CAPSULE in 1 BOTTLE (50090-5610-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 26, 1999 | TE: | AB | RLD: | No |
Complete Access Available with Subscription